You are visiting a website that is not intended for your region

The page or information you have requested is intended for an audience outside the United States. By continuing to browse you confirm that you are a non-US resident requesting access to this page or information.

Switch to the US site

Cardiosave Platform

Don’t miss a beat. Count on Cardiosave.

When your patients are counting on you, don’t miss a beat. Count on Getinge’s Cardiosave platform as your first line of mechanical circulatory support.

Faster time to therapy

Fast time to therapy[1]

Cardiosave’s proprietary, fiber-optic IABs automatically calibrate in the patient after insertion so you won’t have to worry about calibrating and zeroing the pump. When timing is critical, you can count on Cardiosave for the first line of mechanical circulatory support.

  • Automatic in-vivo calibration
  • One button to therapy
  • Instant signal transmission
  • Crisp, clean arterial pressure waveform

Learn more about the Cardiosave IABP Hybrid

The Getinge Cardiosave® Platform minimizes adverse events.

Getinge’s portfolio of 7Fr, 7.5Fr and 8Fr intra-aortic balloon catheters allow you to provide patients with hemodynamic support without the increased risk of vascular complications associated with large bore catheters.[2] When patient safety is on the line, you can count on the Cardiosave Platform as your first line of mechanical circulatory support.[3]

  • Reduced risk of vascular complications[4]
  • Reduced risk of bleeding[2]*
  • Reduced hospital stay and cost[2]*
  • IABP Therapy delivers equivalent outcomes[2]*

*Compared to large bore catheters

The right combination of IABP and catheter to treat even your most complex patients

The Cardiosave IABP, combined with our Getinge high efficacy balloons – MEGA (Standard-pressure) and Sensation Plus (fiber-optic) – allows you to provide greater support and may help you stabilize your patients as quickly as possible.[5] When you need support, you can count on Cardiosave with a high-efficacy balloon as your first line of mechanical circulatory support.

  • Delivers additional cardiac output of up to 1.6 L/min[6]
  • More volume displacement[5]
  • Great diastolic augmentation[5]
  • Greater afterload reduction[5]

The Getinge Cardiosave® Platform makes transporting patients fast and easy.

The Cardiosave Hybrid is uniquely designed to easily convert to the smaller and lighter Rescue mobile unit when transporting patients from an ambulance to another facility. Whether you are moving your patient from room-to-room or between hospitals, you can count on the Cardiosave Platform as your first line of mechanical circulatory support.

  • Small footprint and lightweight design[1]
  • Simply remove pump console and go
  • Unique accessories for extended transport usage
  • Unmatched transport capabilities[1]

Learn more about IABP Solutions

Watch on-demand webinars with leaders in interventional cardiology. Read about the clinical and economic effectiveness of pVADS or the hemodynamic effects of standard vs large capacity IABC pumps. Learn about the why, when and who of mechanical circulatory support.

Learn more...

All references

  1. 1. Data on file.

  2. 2. Redfors et al. Mortality, Length of Stay, and Cost Implications of Procedural Bleeding Aer Percutaneous Interventions Using Large-Bore Catheters. JAMA Cardiology. 2017;2(7):798-802. doi: 10.1001/jamacardio.2017.0265

  3. 3. Amin AP, Spertus JA, Curtis JP, et al. The evolving landscape of Impella use in the United States among patients undergoing percutaneous coronary intervention with mechanical circulatory support. Circulation. 2019; Epub ahead of print.

  4. 4. Schrage, et al. Impella Support for Cardiogenic Shock. 10.1161/CIRCULATIONAHA.118.036614.

  5. 5. Kapur et al. Hemodynamic Effects of Standard Versus Larger-Capacity Intraaortic Balloon Counterpulsation Pumps. J INVASIVE CARDIOL 2015;27(4):182-188.

  6. 6. Baran et al. Differential Responses to Larger Volume Intraaortic Balloon Counterpulsation: Hemodynamic and Clinical Outcomes. CATHETER CARDIOVASC IINTERV. 2017;1–8. (The mean increase in cardiac output with the MEGA 50 IABC was 1.6 +/-)